Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of CYP2C9, HLA-A and HLA-B with anti-epileptic drugs.

Autor: Manson LEN; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands., Nijenhuis M; Royal Dutch Pharmacists Association (KNMP), The Hague, The Netherlands. M.Nijenhuis@knmp.nl., Soree B; Royal Dutch Pharmacists Association (KNMP), The Hague, The Netherlands., de Boer-Veger NJ; Pharmacy Boterdiep, Groningen, The Netherlands., Buunk AM; Pharmacy De Katwijkse Apotheek, Katwijk, The Netherlands., Houwink EJF; Department of Family Medicine, Mayo Clinic, Rochester, MN, USA., Risselada A; Department of Clinical Pharmacy, Wilhelmina Hospital, Assen, The Netherlands., Rongen GAPJM; Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Pharmacology and Toxicology, Radboud University Medical Center, Nijmegen, The Netherlands., van Schaik RHN; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands., Swen JJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands., Touw DJ; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Department of Pharmaceutical Analysis, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands., van Westrhenen R; Department of Psychiatry, Parnassia Group, Amsterdam, The Netherlands.; Department of Psychiatry and Neuropsychology, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.; Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King's College London, London, UK., Deneer VHM; Department of Clinical Pharmacy, Division Laboratories, Pharmacy and Biomedical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.

Publikováno v: European journal of human genetics : EJHG [Eur J Hum Genet] 2024 Aug; Vol. 32 (8), pp. 903-911. Date of Electronic Publication: 2024 Apr 03.

The PREPARE study: benefits of pharmacogenetic testing are unclear - Authors' reply.

Autor: Swen JJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, 2300 RC Leiden, Netherlands., Manson LEN; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, 2300 RC Leiden, Netherlands., Böhringer S; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, 2300 RC Leiden, Netherlands; Department of Biomedical Data Sciences, Leiden University Medical Center, 2300 RC Leiden, Netherlands., Pirmohamed M; Department of Pharmacology and Therapeutics, Wolfson Centre for Personalised Medicine, University of Liverpool, Liverpool, UK., Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, 2300 RC Leiden, Netherlands. Electronic address: h.j.guchelaar@lumc.nl.

Publikováno v: Lancet (London, England) [Lancet] 2023 Jun 03; Vol. 401 (10391), pp. 1851-1852.

Genotyping for HLA Risk Alleles to Prevent Drug Hypersensitivity Reactions: Impact Analysis.

Autor: Manson LEN; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.; Leiden Network for Personalized Therapeutics, 2333 ZA Leiden, The Netherlands., van den Hout WB; Department of Biomedical Data Sciences, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands., Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.; Leiden Network for Personalized Therapeutics, 2333 ZA Leiden, The Netherlands.

Publikováno v: Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2021 Dec 21; Vol. 15 (1). Date of Electronic Publication: 2021 Dec 21.